Canntab Therapeutics Limited (CTABF) has a market capitalization of $3.89K and trades at $0.00. The 52-week range is 0.0001-0.0073.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-0.10, annual revenue of $293.36K.
The stock has a beta of 1.42, operates in the Healthcare sector.
